Sopharma AD (WSE:SPH)
Poland
· Delayed Price · Currency is PLN 12.50
+0.10 (0.81%)
Apr 2, 2025, 6:55 PM CET
Sopharma AD Revenue
In the year 2024, Sopharma AD had annual revenue of 2.14B BGN with 13.27% growth. Sopharma AD had revenue of 587.96M in the quarter ending December 31, 2024, with 16.63% growth.
Revenue
2.14B BGN
Revenue Growth
+13.27%
P/S Ratio
n/a
Revenue / Employee
382.12K BGN
Employees
5,599
Market Cap
2.06B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
| Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
| Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
| Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
| Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 492.41M |
| Celon Pharma | 209.54M |
| Selvita | 345.76M |
| Ryvu Therapeutics | 101.96M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Scope Fluidics | 119.00K |